AVAI BIO, INC.: 10-K filed 2022-06-29

Name: AVAI BIO, INC.: 10-K filed 2022-06-29
Creator: AVAI BIO, INC.

What AVAI BIO, INC. reported in its annual report filed 2022-06-29 (fiscal FY 2022): 27 published measures, 55 facts as tagged in accession 0001740797-22-000007.

This filing

Form: 10-K (annual report)
Filed: 2022-06-29
Fiscal period: fiscal FY 2022
Accession: 0001740797-22-000007 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AVAI BIO, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-03-31	454,664	USD
At 2021-03-31	816,269	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-03-31	860,225	USD
At 2021-03-31	1,143,682	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2022-03-31	-405,561	USD
At 2021-03-31	-327,413	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2022-03-31	33,289	USD
At 2021-03-31	60,364	USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	535,008	USD	365
2020-04-01 to 2021-03-31	23,090	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	474,214	USD	365
2020-04-01 to 2021-03-31	34,785	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	-33,719	USD	365
2020-04-01 to 2021-03-31	-21,368	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-03-31	495,851	USD
At 2021-03-31	369,330	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	26,316,083	shares	365
2020-04-01 to 2021-03-31	26,281,600	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	0	USD/shares	365
2020-04-01 to 2021-03-31	0	USD/shares	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2022-03-31	1,500	USD
At 2021-03-31	1,500	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	126,521	USD	365
2020-04-01 to 2021-03-31	302,292	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-03-31	330,872	USD
At 2021-03-31	620,293	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2022-03-31	860,225	USD
At 2021-03-31	1,143,682	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2022-03-31	1,986	USD
At 2021-03-31	270,923	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2022-03-31	3,765	USD
At 2021-03-31	63,629	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	553,920	USD	365
2020-04-01 to 2021-03-31	287,188	USD	365

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	210,794	USD	365
2020-04-01 to 2021-03-31	-16,536	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit
At 2022-03-31	26,316,083	shares
At 2021-03-31	26,281,600	shares
At 2020-03-31	1,064,080	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-03-31	60,193	USD
At 2021-03-31	293	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2022-03-31	169	USD
At 2021-03-31	-11,392	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2022-03-31	1,075	USD
At 2021-03-31	12,015	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2022-03-31	2,816	USD
At 2021-03-31	1,167	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	-126,521	USD	365
2020-04-01 to 2021-03-31	-302,292	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	449,361	USD	365
2020-04-01 to 2021-03-31	205,301	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	-59,864	USD	365
2020-04-01 to 2021-03-31	34,055	USD	365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2021-04-01 to 2022-03-31	268,936	USD	365
2020-04-01 to 2021-03-31	-220,106	USD	365

Inspect the source

Entity: AVAI BIO, INC. / CIK 0001740797
Captured: 2026-09-21T17:25:43.217Z
SEC response SHA-256: 517998bc0cdcf6cacd8a8d0f1fd509d15f40cb7868ef1a28e1bc010be8dc1c03

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001740797.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))